FDA.reportPublic FDA data

Vyvanse 40 MG Oral Capsule

RxCUI
854840
RxNorm name
Vyvanse 40 MG Oral Capsule
Display name
Vyvanse 40 MG Oral Capsule
Full name
Vyvanse 40 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VyvanseLISDEXAMFETAMINE DIMESYLATETakeda Pharmaceuticals America, Inc.704e4378-ca83-445c-8b45-3cfa51c1ecad2026-04-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 854840

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
704e4378-ca83-445c-8b45-3cfa51c1ecadVyvanse 40 MG Oral Capsule [PSN] · lisdexamfetamine dimesylate 40 MG Oral Capsule [Vyvanse] [SBD] · Vyvanse 40 MG Oral Capsule [SY]381These highlights do not include all the information needed to use VYVANSE safely and effectively. See full prescribing information for VYVANSE. VYVANSE ® (lisdexamfetamine dimesylate) capsules, for oral use, CII VYVANSE ® (lisdexamfetamine dimesylate) chewable tablets, for oral use, CII Initial U.S. Approval: 200720260430
a310fc51-2743-4755-8398-fed5402283f6Vyvanse 40 MG Oral Capsule [PSN] · lisdexamfetamine dimesylate 40 MG Oral Capsule [Vyvanse] [SBD] · Vyvanse 40 MG Oral Capsule [SY]34These highlights do not include all the information needed to use Vyvanse safely and effectively. See full prescribing information for Vyvanse. Vyvanse ® (lisdexamfetamine dimesylate) Capsules, CII Initial U.S. Approval: 200720120113